News World
Low-cost HIV prevention injection receives FDA approval for rollout in 120 countries
Lenacapavir is a long-acting injectable used to prevent HIV, administered twice a year
News World
Lenacapavir is a long-acting injectable used to prevent HIV, administered twice a year
News UK
NICE said its cost-effectiveness was above the range considered an acceptable use of NHS resources
News UK
NHS England estimates that around 300 people could receive the treatment within three years